tirzepatide patent expiry 2036 eli lilly In weight loss battle, Novo and face growing offensive from licensed copies Mounjaro, Zepbound: Generic GLP-1 Drugs

These options differ significantly in mechanism, regulatory status, and clinical evidence

The medication typically starts with a small dosage, gradually increasing to a maintenance level as patients adjust to potential side effects

Primary care providers, who write the bulk of GLP-1 prescriptions, seldom have the resources or time to deliver effective weight management support (source)

Long-Term Use: As of now, the long-term effects of GLP-1 use for weight loss are not well-known

Paul Edison, a professor of science at Imperial College in London who led the study, will present more details about the research during a Tuesday afternoon session at the AAIC meeting in Philadelphia